| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurodevelopmental Disorders | 12 | 2024 | 500 | 1.270 |
Why?
|
| Intellectual Disability | 19 | 2024 | 1054 | 1.180 |
Why?
|
| Abnormalities, Multiple | 18 | 2022 | 956 | 0.800 |
Why?
|
| Phenotype | 24 | 2024 | 4252 | 0.670 |
Why?
|
| De Lange Syndrome | 4 | 2023 | 44 | 0.590 |
Why?
|
| Developmental Disabilities | 12 | 2023 | 712 | 0.530 |
Why?
|
| Chromosomes, Human, X | 3 | 2012 | 157 | 0.530 |
Why?
|
| Facies | 6 | 2021 | 153 | 0.490 |
Why?
|
| Mutation | 15 | 2023 | 5821 | 0.490 |
Why?
|
| Microcephaly | 7 | 2023 | 330 | 0.450 |
Why?
|
| Transcription Factors | 11 | 2023 | 2582 | 0.420 |
Why?
|
| Movement Disorders | 3 | 2023 | 220 | 0.420 |
Why?
|
| Genetic Association Studies | 6 | 2023 | 778 | 0.410 |
Why?
|
| Beckwith-Wiedemann Syndrome | 1 | 2012 | 16 | 0.400 |
Why?
|
| Mutation, Missense | 8 | 2023 | 875 | 0.390 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2012 | 71 | 0.380 |
Why?
|
| Chromosome Deletion | 8 | 2014 | 647 | 0.380 |
Why?
|
| Chromosomes, Human, Pair 16 | 5 | 2018 | 150 | 0.370 |
Why?
|
| Craniofacial Abnormalities | 7 | 2021 | 239 | 0.370 |
Why?
|
| DNA Copy Number Variations | 6 | 2018 | 947 | 0.330 |
Why?
|
| Histones | 2 | 2024 | 526 | 0.330 |
Why?
|
| Cerebellar Neoplasms | 1 | 2012 | 275 | 0.320 |
Why?
|
| Medulloblastoma | 1 | 2012 | 325 | 0.320 |
Why?
|
| Nuclear Proteins | 6 | 2023 | 1265 | 0.310 |
Why?
|
| Child | 33 | 2024 | 24354 | 0.290 |
Why?
|
| Child, Preschool | 28 | 2024 | 14000 | 0.280 |
Why?
|
| Myotonic Dystrophy | 2 | 2007 | 149 | 0.280 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2006 | 35 | 0.260 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2021 | 3152 | 0.260 |
Why?
|
| Acrocephalosyndactylia | 1 | 2006 | 22 | 0.260 |
Why?
|
| Genetic Variation | 3 | 2021 | 1493 | 0.260 |
Why?
|
| Persistent Fetal Circulation Syndrome | 2 | 2018 | 89 | 0.260 |
Why?
|
| Male | 48 | 2024 | 61018 | 0.250 |
Why?
|
| Mosaicism | 3 | 2022 | 239 | 0.250 |
Why?
|
| Myotonin-Protein Kinase | 3 | 2020 | 45 | 0.250 |
Why?
|
| Haploinsufficiency | 4 | 2023 | 258 | 0.250 |
Why?
|
| Homozygote | 1 | 2007 | 548 | 0.250 |
Why?
|
| Cell Cycle Proteins | 3 | 2023 | 641 | 0.240 |
Why?
|
| Humans | 67 | 2024 | 124227 | 0.240 |
Why?
|
| Adolescent | 25 | 2024 | 19260 | 0.230 |
Why?
|
| Chromosome Aberrations | 4 | 2022 | 616 | 0.230 |
Why?
|
| Sequence Deletion | 3 | 2016 | 526 | 0.230 |
Why?
|
| Infant | 22 | 2021 | 12464 | 0.210 |
Why?
|
| Female | 48 | 2024 | 66301 | 0.210 |
Why?
|
| Exons | 3 | 2017 | 796 | 0.210 |
Why?
|
| Gene Duplication | 5 | 2015 | 361 | 0.200 |
Why?
|
| Glypicans | 2 | 2013 | 39 | 0.200 |
Why?
|
| Ring Chromosomes | 1 | 2022 | 12 | 0.200 |
Why?
|
| Prader-Willi Syndrome | 1 | 2023 | 67 | 0.200 |
Why?
|
| Micrognathism | 1 | 2022 | 65 | 0.200 |
Why?
|
| Infant, Newborn | 19 | 2021 | 8189 | 0.200 |
Why?
|
| Malformations of Cortical Development | 1 | 2022 | 51 | 0.190 |
Why?
|
| Hand Deformities, Congenital | 1 | 2022 | 88 | 0.190 |
Why?
|
| Glutamate-tRNA Ligase | 1 | 2021 | 1 | 0.190 |
Why?
|
| Gene Rearrangement | 3 | 2019 | 319 | 0.190 |
Why?
|
| Small-Conductance Calcium-Activated Potassium Channels | 1 | 2020 | 13 | 0.180 |
Why?
|
| Exome | 4 | 2020 | 1033 | 0.180 |
Why?
|
| Heterozygote | 4 | 2020 | 671 | 0.180 |
Why?
|
| Holoprosencephaly | 3 | 2009 | 23 | 0.180 |
Why?
|
| Leukoencephalopathies | 1 | 2021 | 59 | 0.180 |
Why?
|
| Histone Acetyltransferases | 1 | 2021 | 314 | 0.170 |
Why?
|
| Mental Disorders | 3 | 2015 | 820 | 0.170 |
Why?
|
| Hepatoblastoma | 1 | 2022 | 179 | 0.170 |
Why?
|
| Epilepsy | 3 | 2021 | 871 | 0.170 |
Why?
|
| Cataract | 2 | 2004 | 222 | 0.170 |
Why?
|
| Comparative Genomic Hybridization | 8 | 2016 | 571 | 0.170 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2021 | 244 | 0.170 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 2019 | 30 | 0.170 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2021 | 116 | 0.170 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2019 | 12 | 0.160 |
Why?
|
| Genotype | 8 | 2021 | 2556 | 0.160 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2019 | 19 | 0.160 |
Why?
|
| Cockayne Syndrome | 2 | 2004 | 6 | 0.160 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 2 | 2019 | 27 | 0.160 |
Why?
|
| Histone Deacetylases | 2 | 2023 | 110 | 0.160 |
Why?
|
| Cohort Studies | 9 | 2021 | 4779 | 0.160 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2017 | 263 | 0.160 |
Why?
|
| INDEL Mutation | 1 | 2019 | 87 | 0.150 |
Why?
|
| Genome, Human | 3 | 2017 | 1260 | 0.150 |
Why?
|
| Amino Acid Substitution | 1 | 2019 | 393 | 0.150 |
Why?
|
| Smith-Magenis Syndrome | 1 | 2019 | 105 | 0.150 |
Why?
|
| Muscle Hypotonia | 1 | 2019 | 187 | 0.150 |
Why?
|
| Noonan Syndrome | 1 | 2018 | 30 | 0.140 |
Why?
|
| Nephrosis | 1 | 2017 | 4 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2008 | 140 | 0.140 |
Why?
|
| Actins | 1 | 2019 | 341 | 0.140 |
Why?
|
| Language Development Disorders | 2 | 2017 | 174 | 0.140 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2019 | 210 | 0.140 |
Why?
|
| Arginine | 1 | 2019 | 332 | 0.140 |
Why?
|
| Urogenital Abnormalities | 2 | 2021 | 154 | 0.140 |
Why?
|
| Adult | 21 | 2024 | 29367 | 0.140 |
Why?
|
| Hernia, Hiatal | 1 | 2017 | 55 | 0.140 |
Why?
|
| Genomic Instability | 1 | 2018 | 228 | 0.140 |
Why?
|
| Endopeptidases | 1 | 2017 | 114 | 0.130 |
Why?
|
| Genomic Imprinting | 2 | 2016 | 123 | 0.130 |
Why?
|
| Multiprotein Complexes | 1 | 2017 | 206 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 2011 | 86 | 0.130 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2016 | 100 | 0.130 |
Why?
|
| Syndrome | 6 | 2023 | 1118 | 0.130 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2023 | 459 | 0.120 |
Why?
|
| Cleavage And Polyadenylation Specificity Factor | 1 | 2015 | 15 | 0.120 |
Why?
|
| MAP Kinase Kinase 6 | 1 | 2015 | 5 | 0.120 |
Why?
|
| Gain of Function Mutation | 1 | 2016 | 104 | 0.120 |
Why?
|
| Pulmonary Alveoli | 1 | 2016 | 134 | 0.120 |
Why?
|
| Translocation, Genetic | 2 | 2022 | 357 | 0.120 |
Why?
|
| Pierre Robin Syndrome | 1 | 2015 | 30 | 0.120 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2011 | 1015 | 0.120 |
Why?
|
| Carrier Proteins | 2 | 2017 | 1022 | 0.120 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2015 | 54 | 0.120 |
Why?
|
| Amino Acid Sequence | 5 | 2021 | 2704 | 0.120 |
Why?
|
| Pedigree | 5 | 2018 | 1605 | 0.120 |
Why?
|
| Frameshift Mutation | 4 | 2020 | 180 | 0.120 |
Why?
|
| SOX9 Transcription Factor | 1 | 2015 | 79 | 0.120 |
Why?
|
| Repressor Proteins | 2 | 2023 | 816 | 0.120 |
Why?
|
| Otx Transcription Factors | 1 | 2014 | 20 | 0.120 |
Why?
|
| Young Adult | 9 | 2021 | 8999 | 0.110 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2017 | 358 | 0.110 |
Why?
|
| Pulmonary Veins | 1 | 2016 | 161 | 0.110 |
Why?
|
| Cranial Fontanelles | 1 | 2014 | 4 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2014 | 118 | 0.110 |
Why?
|
| Hypertelorism | 1 | 2014 | 11 | 0.110 |
Why?
|
| Gigantism | 1 | 2013 | 14 | 0.110 |
Why?
|
| Saccule and Utricle | 1 | 2013 | 12 | 0.110 |
Why?
|
| Genes, X-Linked | 1 | 2014 | 59 | 0.110 |
Why?
|
| Gene Dosage | 1 | 2015 | 439 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2023 | 555 | 0.110 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2017 | 443 | 0.110 |
Why?
|
| Heart Defects, Congenital | 5 | 2021 | 1813 | 0.110 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2013 | 64 | 0.110 |
Why?
|
| Brain Neoplasms | 1 | 2022 | 1207 | 0.100 |
Why?
|
| Eye Abnormalities | 1 | 2014 | 104 | 0.100 |
Why?
|
| Fractures, Bone | 1 | 2015 | 187 | 0.100 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2015 | 309 | 0.100 |
Why?
|
| Liver Neoplasms | 1 | 2022 | 1310 | 0.100 |
Why?
|
| DNA-Binding Proteins | 3 | 2022 | 2044 | 0.100 |
Why?
|
| In Situ Hybridization, Fluorescence | 5 | 2022 | 762 | 0.090 |
Why?
|
| Autism Spectrum Disorder | 1 | 2017 | 384 | 0.090 |
Why?
|
| Gene Deletion | 4 | 2017 | 791 | 0.090 |
Why?
|
| DNA Mutational Analysis | 5 | 2019 | 793 | 0.090 |
Why?
|
| RNA, Messenger | 3 | 2015 | 2815 | 0.090 |
Why?
|
| Germ Cells | 2 | 2022 | 194 | 0.090 |
Why?
|
| Inheritance Patterns | 2 | 2009 | 127 | 0.090 |
Why?
|
| Tetrasomy | 1 | 2010 | 1 | 0.090 |
Why?
|
| Prostate | 1 | 2013 | 435 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2011 | 57 | 0.090 |
Why?
|
| Anemia, Diamond-Blackfan | 1 | 2010 | 10 | 0.090 |
Why?
|
| Segmental Duplications, Genomic | 4 | 2011 | 81 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2010 | 72 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2010 | 62 | 0.090 |
Why?
|
| Nucleic Acid Hybridization | 2 | 2008 | 395 | 0.090 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2010 | 98 | 0.090 |
Why?
|
| Sequence Alignment | 4 | 2017 | 622 | 0.090 |
Why?
|
| Chromosome Duplication | 1 | 2010 | 147 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2010 | 160 | 0.080 |
Why?
|
| HEK293 Cells | 2 | 2023 | 744 | 0.080 |
Why?
|
| Chromosome Disorders | 2 | 2011 | 311 | 0.080 |
Why?
|
| Karyotyping | 3 | 2022 | 328 | 0.080 |
Why?
|
| Trisomy | 2 | 2000 | 102 | 0.080 |
Why?
|
| Recombination, Genetic | 1 | 2011 | 448 | 0.080 |
Why?
|
| Genes, Dominant | 2 | 2007 | 245 | 0.080 |
Why?
|
| Molecular Sequence Data | 6 | 2014 | 3877 | 0.080 |
Why?
|
| Scrotum | 2 | 2021 | 24 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2008 | 103 | 0.070 |
Why?
|
| Intracranial Thrombosis | 1 | 2007 | 12 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2009 | 369 | 0.070 |
Why?
|
| Alleles | 4 | 2021 | 1614 | 0.070 |
Why?
|
| Cystine | 1 | 2006 | 15 | 0.070 |
Why?
|
| Cognition Disorders | 1 | 2010 | 553 | 0.060 |
Why?
|
| Animals | 11 | 2021 | 34067 | 0.060 |
Why?
|
| Urinary Bladder | 2 | 2019 | 245 | 0.060 |
Why?
|
| Whole Genome Sequencing | 2 | 2017 | 277 | 0.060 |
Why?
|
| Serine | 1 | 2006 | 173 | 0.060 |
Why?
|
| Fatal Outcome | 1 | 2006 | 355 | 0.060 |
Why?
|
| Pre-Eclampsia | 1 | 2007 | 221 | 0.060 |
Why?
|
| Forkhead Transcription Factors | 2 | 2018 | 356 | 0.060 |
Why?
|
| Homeodomain Proteins | 2 | 2017 | 543 | 0.060 |
Why?
|
| Protein Conformation | 2 | 2017 | 830 | 0.060 |
Why?
|
| Mice | 7 | 2021 | 17627 | 0.060 |
Why?
|
| Zebrafish | 2 | 2017 | 384 | 0.060 |
Why?
|
| Blepharophimosis | 2 | 2021 | 26 | 0.060 |
Why?
|
| Pituitary Gland | 1 | 2003 | 82 | 0.050 |
Why?
|
| Models, Molecular | 2 | 2017 | 1069 | 0.050 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2023 | 25 | 0.050 |
Why?
|
| Hyperphagia | 1 | 2023 | 45 | 0.050 |
Why?
|
| Cleft Palate | 1 | 2005 | 140 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 4344 | 0.050 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2023 | 154 | 0.050 |
Why?
|
| Oxytocin | 1 | 2023 | 69 | 0.050 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2002 | 14 | 0.050 |
Why?
|
| Homocystinuria | 1 | 2002 | 23 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 1 | 2023 | 221 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2022 | 78 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2020 | 3552 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2023 | 325 | 0.050 |
Why?
|
| Pregnancy | 8 | 2015 | 7180 | 0.050 |
Why?
|
| Autistic Disorder | 2 | 2020 | 343 | 0.050 |
Why?
|
| Congenital Hypothyroidism | 1 | 2021 | 6 | 0.050 |
Why?
|
| Patella | 1 | 2021 | 25 | 0.050 |
Why?
|
| Psychomotor Disorders | 1 | 2021 | 28 | 0.050 |
Why?
|
| Neurodegenerative Diseases | 1 | 2024 | 249 | 0.050 |
Why?
|
| Joint Instability | 1 | 2021 | 42 | 0.050 |
Why?
|
| Amino Acyl-tRNA Synthetases | 1 | 2021 | 26 | 0.050 |
Why?
|
| Dysostoses | 1 | 2000 | 2 | 0.050 |
Why?
|
| Trans-Activators | 2 | 2007 | 800 | 0.050 |
Why?
|
| Scapula | 1 | 2000 | 12 | 0.050 |
Why?
|
| Chromosome Mapping | 3 | 2011 | 1079 | 0.040 |
Why?
|
| Acidosis, Lactic | 1 | 2021 | 30 | 0.040 |
Why?
|
| Shoulder | 1 | 2000 | 27 | 0.040 |
Why?
|
| Electrophysiological Phenomena | 1 | 2020 | 67 | 0.040 |
Why?
|
| Chromosome Breakage | 2 | 2011 | 167 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2000 | 94 | 0.040 |
Why?
|
| Pelvis | 1 | 2000 | 71 | 0.040 |
Why?
|
| Branchio-Oto-Renal Syndrome | 1 | 2000 | 11 | 0.040 |
Why?
|
| Face | 2 | 2019 | 179 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2023 | 429 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2016 | 869 | 0.040 |
Why?
|
| Reproduction | 1 | 2002 | 238 | 0.040 |
Why?
|
| Cerebellar Ataxia | 1 | 2020 | 65 | 0.040 |
Why?
|
| Patch-Clamp Techniques | 1 | 2020 | 282 | 0.040 |
Why?
|
| Genetic Counseling | 1 | 2021 | 220 | 0.040 |
Why?
|
| Genetic Loci | 1 | 2021 | 339 | 0.040 |
Why?
|
| Paraganglioma | 1 | 1999 | 19 | 0.040 |
Why?
|
| Codon, Terminator | 1 | 2019 | 26 | 0.040 |
Why?
|
| Hearing Disorders | 1 | 1999 | 25 | 0.040 |
Why?
|
| Osteochondrodysplasias | 1 | 2000 | 66 | 0.040 |
Why?
|
| Stroke | 1 | 2007 | 976 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2019 | 2629 | 0.040 |
Why?
|
| Megalencephaly | 1 | 2019 | 57 | 0.040 |
Why?
|
| Cornea | 1 | 2004 | 654 | 0.040 |
Why?
|
| Molecular Biology | 1 | 1999 | 79 | 0.040 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 1999 | 61 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2020 | 149 | 0.040 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 1999 | 72 | 0.040 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2019 | 70 | 0.040 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2019 | 118 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 1998 | 49 | 0.040 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2018 | 32 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2019 | 154 | 0.040 |
Why?
|
| White Matter | 1 | 2020 | 178 | 0.040 |
Why?
|
| Alu Elements | 1 | 2018 | 65 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 2084 | 0.040 |
Why?
|
| Zinc Fingers | 1 | 1998 | 120 | 0.040 |
Why?
|
| Hearing Loss | 1 | 2019 | 134 | 0.040 |
Why?
|
| Middle Aged | 4 | 2020 | 26605 | 0.040 |
Why?
|
| Bone and Bones | 1 | 2000 | 265 | 0.040 |
Why?
|
| Kidney | 2 | 2021 | 1357 | 0.040 |
Why?
|
| Telomere Homeostasis | 1 | 2017 | 42 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 1999 | 418 | 0.030 |
Why?
|
| Nephrotic Syndrome | 1 | 2017 | 48 | 0.030 |
Why?
|
| RNA, Transfer | 1 | 2017 | 72 | 0.030 |
Why?
|
| Colon | 1 | 2019 | 351 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2017 | 124 | 0.030 |
Why?
|
| Metalloendopeptidases | 1 | 2017 | 101 | 0.030 |
Why?
|
| Point Mutation | 1 | 2018 | 346 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2017 | 79 | 0.030 |
Why?
|
| Siblings | 1 | 2018 | 197 | 0.030 |
Why?
|
| Glaucoma | 1 | 1997 | 87 | 0.030 |
Why?
|
| Podocytes | 1 | 2017 | 74 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2018 | 406 | 0.030 |
Why?
|
| Anxiety | 1 | 2023 | 941 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2017 | 120 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2018 | 227 | 0.030 |
Why?
|
| Zebrafish Proteins | 1 | 2017 | 113 | 0.030 |
Why?
|
| Genetic Linkage | 1 | 2018 | 453 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2017 | 178 | 0.030 |
Why?
|
| Mitochondria | 1 | 2021 | 681 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2019 | 579 | 0.030 |
Why?
|
| Genes, Lethal | 1 | 2016 | 76 | 0.030 |
Why?
|
| Craniosynostoses | 2 | 2013 | 133 | 0.030 |
Why?
|
| Pandemics | 1 | 2023 | 1096 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 1995 | 59 | 0.030 |
Why?
|
| Genomics | 1 | 2023 | 1492 | 0.030 |
Why?
|
| Cataract Extraction | 1 | 1997 | 216 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2018 | 669 | 0.030 |
Why?
|
| Polyadenylation | 1 | 2015 | 55 | 0.030 |
Why?
|
| Head and Neck Neoplasms | 1 | 1999 | 489 | 0.030 |
Why?
|
| Dystonic Disorders | 1 | 2016 | 85 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2017 | 253 | 0.030 |
Why?
|
| Microsatellite Repeats | 3 | 2000 | 220 | 0.030 |
Why?
|
| Genitalia | 1 | 2014 | 35 | 0.030 |
Why?
|
| Base Sequence | 3 | 2011 | 3089 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2017 | 698 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2016 | 484 | 0.030 |
Why?
|
| DNA Repair | 1 | 2017 | 585 | 0.030 |
Why?
|
| Cell Movement | 1 | 2017 | 835 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 1328 | 0.030 |
Why?
|
| Urethral Diseases | 1 | 2013 | 17 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2015 | 406 | 0.030 |
Why?
|
| Pathology, Molecular | 1 | 2013 | 58 | 0.030 |
Why?
|
| Cerebellum | 1 | 1997 | 412 | 0.030 |
Why?
|
| Disorders of Sex Development | 1 | 2013 | 71 | 0.030 |
Why?
|
| Penis | 1 | 2013 | 98 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 1998 | 716 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 4402 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2022 | 16276 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 5127 | 0.020 |
Why?
|
| Seizures | 1 | 2017 | 874 | 0.020 |
Why?
|
| Agenesis of Corpus Callosum | 2 | 2004 | 41 | 0.020 |
Why?
|
| Gene Order | 1 | 2011 | 79 | 0.020 |
Why?
|
| Aged | 2 | 2007 | 19545 | 0.020 |
Why?
|
| Receptors, Odorant | 1 | 2011 | 36 | 0.020 |
Why?
|
| Growth Disorders | 2 | 2005 | 208 | 0.020 |
Why?
|
| Apoptosis | 1 | 2017 | 1784 | 0.020 |
Why?
|
| Brain | 1 | 2022 | 2983 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2009 | 29 | 0.020 |
Why?
|
| Multigene Family | 1 | 2011 | 298 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2017 | 1533 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 1995 | 1697 | 0.020 |
Why?
|
| Radiography | 2 | 2000 | 818 | 0.020 |
Why?
|
| Hirsutism | 1 | 2007 | 20 | 0.020 |
Why?
|
| Family | 1 | 2011 | 562 | 0.020 |
Why?
|
| Protein S | 1 | 2007 | 10 | 0.020 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 2007 | 19 | 0.020 |
Why?
|
| Protein C | 1 | 2007 | 21 | 0.020 |
Why?
|
| Prothrombin | 1 | 2007 | 25 | 0.020 |
Why?
|
| Factor V | 1 | 2007 | 18 | 0.020 |
Why?
|
| Antithrombin III | 1 | 2007 | 25 | 0.020 |
Why?
|
| Pregnancy Outcome | 2 | 2002 | 588 | 0.020 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2007 | 53 | 0.020 |
Why?
|
| X Chromosome Inactivation | 1 | 2007 | 62 | 0.020 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2007 | 70 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 1586 | 0.020 |
Why?
|
| Cerebral Arteries | 1 | 2007 | 80 | 0.020 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2009 | 223 | 0.020 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2007 | 124 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2007 | 302 | 0.020 |
Why?
|
| Family Health | 1 | 2007 | 258 | 0.020 |
Why?
|
| Lipoprotein(a) | 1 | 2007 | 125 | 0.020 |
Why?
|
| Recurrence | 1 | 2009 | 1420 | 0.020 |
Why?
|
| Schizophrenia | 1 | 2008 | 300 | 0.020 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2010 | 401 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2007 | 368 | 0.010 |
Why?
|
| Risk Factors | 2 | 2010 | 10239 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2011 | 1748 | 0.010 |
Why?
|
| Microphthalmos | 1 | 2004 | 60 | 0.010 |
Why?
|
| Zinc Finger Protein Gli2 | 1 | 2003 | 12 | 0.010 |
Why?
|
| Prosencephalon | 1 | 2003 | 39 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2003 | 117 | 0.010 |
Why?
|
| Xenopus | 1 | 2003 | 111 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2004 | 203 | 0.010 |
Why?
|
| COS Cells | 1 | 2003 | 275 | 0.010 |
Why?
|
| Placenta | 1 | 2007 | 506 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 319 | 0.010 |
Why?
|
| Prevalence | 1 | 2009 | 2445 | 0.010 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2003 | 108 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2003 | 461 | 0.010 |
Why?
|
| Homocystine | 1 | 2002 | 3 | 0.010 |
Why?
|
| Pyridoxine | 1 | 2002 | 14 | 0.010 |
Why?
|
| Amino Acids, Sulfur | 1 | 2002 | 15 | 0.010 |
Why?
|
| Drug Resistance | 1 | 2002 | 257 | 0.010 |
Why?
|
| Transfection | 1 | 2003 | 1062 | 0.010 |
Why?
|
| Phylogeny | 1 | 2003 | 695 | 0.010 |
Why?
|
| Genitalia, Male | 1 | 2000 | 38 | 0.010 |
Why?
|
| Skin Abnormalities | 1 | 2000 | 33 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 1284 | 0.010 |
Why?
|
| Autopsy | 1 | 2000 | 111 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2003 | 759 | 0.010 |
Why?
|
| Genitalia, Female | 1 | 2000 | 47 | 0.010 |
Why?
|
| Genetic Heterogeneity | 1 | 2000 | 126 | 0.010 |
Why?
|
| Nutritional Status | 1 | 2002 | 314 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 2000 | 185 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2000 | 78 | 0.010 |
Why?
|
| Delivery, Obstetric | 1 | 2002 | 250 | 0.010 |
Why?
|
| Amino Acids | 1 | 2002 | 663 | 0.010 |
Why?
|
| Ear, External | 1 | 1999 | 22 | 0.010 |
Why?
|
| Decision Trees | 1 | 1999 | 49 | 0.010 |
Why?
|
| Lod Score | 1 | 1999 | 120 | 0.010 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1999 | 81 | 0.010 |
Why?
|
| Teratogens | 1 | 1999 | 88 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 1998 | 70 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 1881 | 0.010 |
Why?
|
| Limb Deformities, Congenital | 1 | 1999 | 106 | 0.010 |
Why?
|
| Amniocentesis | 1 | 1998 | 77 | 0.010 |
Why?
|
| alpha-Fetoproteins | 1 | 1998 | 132 | 0.010 |
Why?
|
| Gene Library | 1 | 1998 | 217 | 0.010 |
Why?
|
| Haplotypes | 1 | 1999 | 515 | 0.010 |
Why?
|
| Introns | 1 | 1998 | 299 | 0.010 |
Why?
|
| Nipples | 1 | 1997 | 6 | 0.010 |
Why?
|
| Dandy-Walker Syndrome | 1 | 1997 | 11 | 0.010 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1999 | 190 | 0.010 |
Why?
|
| Corpus Callosum | 1 | 1997 | 95 | 0.010 |
Why?
|
| Prenatal Diagnosis | 1 | 2000 | 597 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 2003 | 808 | 0.010 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 1997 | 118 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1995 | 80 | 0.010 |
Why?
|
| CHO Cells | 1 | 1995 | 160 | 0.010 |
Why?
|
| DNA | 1 | 2000 | 1595 | 0.010 |
Why?
|
| Cricetinae | 1 | 1995 | 413 | 0.010 |
Why?
|
| Pregnancy Complications | 1 | 1999 | 511 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1995 | 369 | 0.010 |
Why?
|
| Software | 1 | 1998 | 677 | 0.010 |
Why?
|
| Drosophila | 1 | 1998 | 782 | 0.010 |
Why?
|
| Genetic Testing | 1 | 1999 | 998 | 0.010 |
Why?
|
| Algorithms | 1 | 1999 | 1606 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 1995 | 811 | 0.010 |
Why?
|
| Fibroblasts | 1 | 1995 | 882 | 0.010 |
Why?
|